John Gill is the Sr. Director of Research & Innovation at Telesis Bio and was one of the company’s founding team members. He is one of the co-inventors of Telesis Bio’s BioXp platform, which is its flagship product offering for assembling synthetic DNA, and worked on the team that developed the DBC (digital to biological converter). Currently, he and his team are focused on Telesis Bio’s enzymatic DNA synthesis technology, known as SOLA (short oligonucleotide ligation assembly). John earned a BS & MS from East Carolina University.
Interview with John (published January 2023) https://mendelspod.com/podcasts/converting-digital-biological-john-gill-...
